Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3413-3418

  Mandic, Robert ^a   Eikelkamp, Nadine ^a   Peldszus, Roswitha ^a   Sadowski, Maria ^a   Sesterhenn, Andreas M ^a   Dünne, Anja A ^a   Werner, Jochen A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Epidermal growth factor receptor; Expression; Head and neck cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; STAT3 PROTEIN;

ARTICLE; CANCER STAGING; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; WESTERN BLOTTING;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL MEMBRANE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0035569883     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts
2. In vitro activation of Stat3 by epidermal growth factor receptor kinase
3. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
4. Stat3 as an oncogene
5. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
6. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
7. Characterization of an alternatively spliced isoform of rat vesicle associated membrane protein-2 (VAMP-2)
8. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal
9. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
10. Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy
11. The epidermal growth factor receptor family of tyrosine kinases and cancer: Can an atypical exemplar be a sound therapeutic target?
12. Protein tyrosine kinase inhibitors in cancer treatment
13. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway
14. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer cells
15. The biology of erbB-2/neu/HER-2 and its role in cancer
16. Expression of the ErbB3 gene product in breast cancer
17. Ligand-specific activation of HER4/p18OerbB4, a fourth member of the epidermal growth factor receptor family
18. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin
19. Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors
20. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas
21. Structural alterations of the epidermal growth factor receptor gene in human gliomas
22. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
23. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer
24. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas
25. Transformation and altered signal transduction by a naturally occurring mutant EGF receptor
26. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase
27. Growth factor receptor gene mutations and human pathology
28. Expression of an oncogenic mutant EGF receptor markedly increases the sensitivity of cells to and EGF receptor specific antibody toxin
29. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck
30. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
31. Epidermal growth factor: Identification of a new hormone in human urine
32. Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: Oligomerization of kinase domains
33. Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity
34. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers
35. c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells
36. Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors
37. Characterization of the oncogene (erb) of avian erythroblastosis virus and its cellular progenitor